Q1 2026 earnings call: 15% revenue growth, Prime coverage expansion, G7 15 Day rollout, and raised margin outlook.
Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for ...
DexCom (NASDAQ: DXCM) held its first-quarter earnings conference call on Thursday. Below is the complete transcript from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results